Variant report
Variant | nsv441833 |
---|---|
Chromosome Location | chr3:89536456-89547017 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575231105 | chr3:89538200-89538201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143116298 | chr3:89538225-89538226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551091232 | chr3:89538344-89538345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567770803 | chr3:89538355-89538356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534675301 | chr3:89538360-89538361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11706497 | chr3:89538366-89538367 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs370124998 | chr3:89538384-89538385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs146678567 | chr3:89538385-89538386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564252304 | chr3:89538407-89538408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs367861954 | chr3:89538419-89538420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76735850 | chr3:89538436-89538437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184114569 | chr3:89538458-89538459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs972030 | chr3:89538498-89538499 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs554337006 | chr3:89538541-89538542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572907214 | chr3:89538544-89538545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140281642 | chr3:89538547-89538548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564873240 | chr3:89538553-89538554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532188005 | chr3:89538558-89538559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560716932 | chr3:89538591-89538592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114072919 | chr3:89538649-89538650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574407286 | chr3:89538682-89538683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73146907 | chr3:89538747-89538748 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs530986036 | chr3:89538759-89538760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550947416 | chr3:89543024-89543025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367653474 | chr3:89543031-89543032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569663547 | chr3:89543035-89543036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548873567 | chr3:89543066-89543067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs62275028 | chr3:89543067-89543068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190564009 | chr3:89543071-89543072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs376823256 | chr3:89543085-89543086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs35819496 | chr3:89543094-89543095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116353112 | chr3:89543117-89543118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534035134 | chr3:89543134-89543135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148689687 | chr3:89543160-89543161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554279294 | chr3:89543186-89543187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572588010 | chr3:89543188-89543189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183315502 | chr3:89543193-89543194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557842311 | chr3:89543220-89543221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576427907 | chr3:89543348-89543349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73146930 | chr3:89543365-89543366 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs187864017 | chr3:89543378-89543379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191033399 | chr3:89543381-89543382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540846216 | chr3:89543386-89543387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs559158807 | chr3:89543390-89543391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544540498 | chr3:89543431-89543432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182739129 | chr3:89543443-89543444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs370652680 | chr3:89543470-89543471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs80244553 | chr3:89543610-89543611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563129182 | chr3:89543658-89543659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530538461 | chr3:89543667-89543668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 19547694 | CNVD |
Cancer | 20164919 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:89538200-89538600 | Enhancers | Adipose Nuclei | Adipose |
2 | chr3:89538200-89538800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr3:89538400-89538800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr3:89543000-89543800 | Enhancers | Fetal Lung | lung |